Terumo celebrates 100-year anniversary in Asia with an eye to the future

Press Releases »

Terumo, a global leader in medical technology, celebrates its centenary in Asia. From humble beginnings as a thermometer manufacturer in 1921, and the first company in 1963 to create disposable syringes in Japan, the company has been providing medical solutions for the healthcare community and quality products to patients.

Terumo Asia Holdings was established as a subsidiary of Terumo Corporation in 2012. The subsidiary oversees 14 Asia entities across 9 countries.

Forged, tested and ready for the next 100 years

During the pandemic, Terumo Asia Holdings was instrumental in supporting scale-up initiatives that government medical systems and the healthcare community required by bringing in COVID-19 centric therapies, setting up plasma therapy centres, building project sites, protocols, supporting disinfection activities, and initiating dialogue between physicians across Asia.

Probir Das, Chairman and Managing Director, Terumo Asia Holdings said: "The pandemic was a test of our organisation's resilience that we passed with flying colours. We are honored to have talented employees globally, along with great channel and business partners, who work daily to serve our customers and advance our efforts in the healthcare industry. The Terumo mentality is to serve our customers and strengthen the community through innovating high-quality products."

As countries shift to an endemic strategy, Terumo will expand its impact through automation and digital integration with hospital information systems and enhance the delivery of healthcare.

Achieving forward momentum through our celebration in Asia

During its centennial year, Terumo Asia Holdings gave back to communities where Associates are based in. This included '100 hours of CSR', which encouraged Associates to give back through ways they are passionate about; and 'Plant A Tree', which helped beautify outdoor environments, and enhance green spaces.

With the theme of "Stride Ahead", Terumo Asia Holdings celebrated the 100th anniversary with 9 different activations over 7 months, which culminated in the achievement of a GUINNESS WORLD RECORDS Title.

In a first of its kind attempt, Terumo Asia Holdings achieved the title with over 500 people across Asia participating for 'the largest online video chain of people passing and using a thermometer'.

Mr Das said: "Achieving our first 100-year milestone is gratifying and proves that our mission is as true now as it was at the beginning. The Guinness World Records title achieved by our Associates and the thermometer is symbolic of our founding in 1921 while demonstrating social responsibility amidst the pandemic. With the celebrations, we reaffirm commitment to our mission and remain undaunted in support of the healthcare community."

Additional quotes:

Akaike Toshiyuki, President, Terumo Philippines Corporation:

"This is a fantastic milestone to achieve. Our core values coupled with our culture of togetherness will see us achieve more as we aim for the next 100 years!"

Florian Deichmann, General Director, Terumo Blood and Cell Technologies Vietnam Co. Ltd:

"Terumo's success is tied to our ability to meet the demands of different cultures and countries. We are excited about our future, and what we will do in the next 100 years!"

Takumi Uchida, General Director, Terumo Vietnam Co. Ltd

"Our common mission of contributing to society through healthcare has served us well as a north star. Our forward momentum continues to build with the provision of ideas, innovation and quality to the healthcare community."

About Terumo

Terumo is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for 100 years. Based in Tokyo and operating globally, Terumo employs more than 25,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.


ข่าวTerumo Corporation+the companyวันนี้

B.Grimm and Sasin Join Hands to Cultivate New skill set and Compassionate Executive Leadership

B.Grimm Power Public Company Limited have joined forces with Sasin School of Management, Chulalongkorn University, to launch the B.Grimm Executive Partnership Program—an advanced leadership development initiative for senior executives navigating the complexities of the digital era and driving social impact. Rooted in the company's long-standing vision of "Doing Business with Compassion," the program integrates cutting-edge business strategy, digital and AI transformation, organizational

Company targets total revenue growth rate... Dusit Thani Public Company Limited enters final stage of strategic roadmap to unlock value — Company targets total revenue growth rate of 25-30% in 2025. ...

Gulftex Co., Ltd., a leading Thai manufac... Gulftex marks 25th anniversary with bold sustainability vision and global safety innovation — Gulftex Co., Ltd., a leading Thai manufacturer of personal p...

Terumo ฉลองครบรอบ 100 ปีในเอเชีย พร้อมก้าวสู่อนาคตอย่างมั่นคง

Terumo (เทอรูโม) ผู้นำระดับโลกด้านเทคโนโลยีทางการแพทย์ ฉลองครบรอบ 100 ปีการดำเนินธุรกิจในเอเชีย ซึ่งเริ่มจากการเป็นผู้ผลิตเทอร์โมมิเตอร์ในปี พ.ศ. 2464 สู่การเป็นบริษัทแรกในญี่ปุ่นที่ผลิตกระบอกฉีดยาชนิดใช้แล้วทิ้งในปี 2506 จากนั้นบริษัท...

Terumo Acquires Quirem Medical to Enhance Its Interventional Oncology Field

Terumo Corporation (TSE: 4543) today announced it has completed the acquisition of Quirem Medical B.V., a Netherlands-based healthcare startup specializing in the development of next-generation microspheres for Selective...

เซ็นเตอร์พัลส์สามารถปิดการขายกิจการบริษัท วาสคุเทค จำกัด

ซูริค, สวิสเซอร์แลนด์, 18 พ.ย. พีอาร์นิวส์ไวร์ / เฟิร์สคอลล์ / เอเชียเน็ท บริษัท เซ็นเตอร์พัลส์ จำกัด (Centerpulse Ltd.) (ชื่อในตลาดหลักทรัพย์นิวยอร์ค : CEP และชื่อในตลาดหลักทรัพย์สวิส : CEPN) เปิดเผยวันนี้ว่าทางบริษัทฯ ได้ขายกิจการบริษัทวาสคุ...

Centerpulse Closes Sale of Vascutek Ltd.

Centerpulse Ltd.(NYSE: CEP, Swiss Stock Market: CEPN) announced today that it has closed the sale of Vascutek Ltd. to Terumo Corporation of Japan. On November 7, 2002, Centerpulse also announced the closing of the sale of IntraTherapeutics, Inc. to ev3 Inc., a...

เซ็นเตอร์พัลส์เตรียมขายบริษัทวาสคูเทค

ซูริค, สวิสเซอร์แลนด์, 4 ต.ค.-พีอาร์นิวส์ไวร์-เฟิร์สทคอล/เอเชียเน็ท บริษัท เซ็นเตอร์พัลส์ (Centerpulse Ltd.) (ชื่อย่อที่จดทะเบียนในตลาดหลักทรัพย์สวิส: CEPN, ชื่อย่อในตลาดหลักทรัพย์นิวยอร์ค: CEP) เปิดเผยว่า บริษัทได้ทำข้อตกลงเพื่อขายธุรกิจหลอดเลือด...

Centerpulse to Sell Vascutek

Centerpulse Ltd (Swiss Stock Market symbol: CEPN, New York Stock Exchange symbol: CEP) announced today that it has entered into a definitive agreement to sell its Vascutek vascular grafts business to Japanese medical device company Terumo Corporation for USD 170 million,...